Timing of Changes in Alzheimer's Disease Plasma Biomarkers as Assessed by Amyloid and Tau scpPET/scp Clocks

Journal:

Annals of Neurology

Published:

2025-09-01

DOI:

10.1002/ana.27285

Affiliations:

20

Authors:

25

Go to article

Institutions	Authors	Share
Washington University in St. Louis (WUSTL), United States of America (USA)	4.000000	0.16
Takeda Pharmaceuticals U.S.A., Inc., United States of America (USA)	3.000000	0.12
AbbVie Deutschland GmbH & Co. KG, Germany	2.000000	0.08
Johnson & Johnson, United States of America (USA)	2.000000	0.08
Biogen, United States of America (USA)	2.000000	0.08
Foundation for the National Institutes of Health (FNIH), United States of America (USA)	2.000000	0.08
Northern California Institute for Research and Education (NCIRE), United States of America (USA)	1.500000	0.06
University of California, San Francisco (UCSF), United States of America (USA)	1.500000	0.06
Sahlgrenska Academy, GU, Sweden	1.166667	0.05
Indiana University Indianapolis (IU Indianapolis), United States of America (USA)	1.000000	0.04
Alzheimer's Association, United States of America (USA)	1.000000	0.04
Enigma Biomedical Group, United States of America (USA)	1.000000	0.04
University of Pennsylvania Health System (UPHS), United States of America (USA)	1.000000	0.04
AbbVie, United States of America (USA)	1.000000	0.04
Sahlgrenska University Hospital (SU), GU, Sweden	0.166667	0.01
UK DRI at UCL (UK DRI UCL), United Kingdom (UK)	0.166667	0.01
UCL Queen Square Institute of Neurology, United Kingdom (UK)	0.166667	0.01
The Hong Kong University of Science and Technology (HKUST), China	0.166667	0.01
University of Wisconsin-Madison (UW-Madison), United States of America (USA)	0.166667	0.01

Interested in Medical Biotechnology?